6.7 Million
Americans are currently living with
Alzheimer’s disease.
141% Increase
in deaths from Alzheimer’s between
2000 and 2021.
$360 Billion
the estimated cost of treating Alzheimer’s in the
United States in 2024.
GAP and our network of over 100 clinical research partners (GAP-Net Sites) around the world collaborate to speed the delivery of Alzheimer’s and Parkinson’s disease treatments, lowering the cost and duration of clinical trials with a commitment to promoting diversity in clinical research, to ensure that no one is left behind.
GAP-Net includes leading private and academic research sites across North America and Europe, connecting neurodegenerative trials to researchers, and researchers to participants with our flagship services, including GAP Participant Services (GPS Liaisons) and our Inclusive Research Initiative (Community Connectors).
20+
GPS Liaisons and Community Connectors providing high-touch support and resources
3500+
GPS visits since 2019, helping bridge sites, community-based organizations, studies
and volunteers
100+
GAP-Net sites in North America and Europe/United Kingdom
Since 2018, GAP has successfully...
Supported
15+
GAP-enabled trialsInitiated
4
GAP-sponsored studies
